Bortezomib-induced apoptosis in cultured pancreatic cancer cells is associated with ceramide production

Ceramide and Apoptosis: Exploring the Enigmatic Connections between Sphingolipid Metabolism and Programmed Cell Death

(2012) Thomas D. Mullen et al.   Anti-Cancer Agents in Medicinal Chemistry

Co-administration phenoxodiol with doxorubicin synergistically inhibit the activity of sphingosine kinase-1 (SphK1), a potential oncogene of osteosarcoma, to suppress osteosarcoma cell growth both in vivo and in vitro

(2012) Chen Yao et al.   Molecular Oncology

Trojan-Horse Nanotube On-Command Intracellular Drug Delivery

(2012) Chia-Hsuan Wu et al.   NANO LETTERS

AACR Highlights: Promise for Treating Pancreatic Cancer

(2011) S. Jenks   JNCI-Journal of the National Cancer Institute

Pancreatic cancer

(2011) Audrey Vincent et al.   LANCET

New insights for early intervention and detection

(2011) Eithne Costello et al.   Nature Reviews Gastroenterology & Hepatology

Ceramide in Chemotherapy of Tumors

(2011) Marie-Therese Dimanche-Boitrel et al.   Recent Patents on Anti-Cancer Drug Discovery

Randomized Phase III Trial of Gemcitabine Plus Cisplatin Compared With Single-Agent Gemcitabine As First-Line Treatment of Patients With Advanced Pancreatic Cancer: The GIP-1 Study

(2010) Giuseppe Colucci et al.   JOURNAL OF CLINICAL ONCOLOGY

Pancreatic Cancer

(2010) Manuel Hidalgo   NEW ENGLAND JOURNAL OF MEDICINE

Pancreatic cancer: molecular pathogenesis and new therapeutic targets

(2009) Han H. Wong et al.   Nature Reviews Gastroenterology & Hepatology

Down-regulation of Phospho-Akt Is a Major Molecular Determinant of Bortezomib-Induced Apoptosis in Hepatocellular Carcinoma Cells

(2008) K.-F. Chen et al.   CANCER RESEARCH

Targeting SphK1 as a New Strategy against Cancer

(2008) Dai Shida et al.   CURRENT DRUG TARGETS